Progress Toward Epigenetic Targeted Therapies for Childhood Cancer

被引：0

作者：

Liapodimitri, Athanasia ^{[1
]}

Tetens, Ashley R. ^{[1
]}

Craig-Schwartz, Jordyn ^{[1
]}

Lunsford, Kayleigh ^{[1
]}

Skalitzky, Kegan O. ^{[1
]}

Koldobskiy, Michael A. ^{[1
,2
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Pediat Oncol, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA

来源：

CANCERS | 2024年 / 16卷 / 24期

关键词：

epigenetics; pediatric cancer; DNA methylation; histone modifications; epigenetic therapy; ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; INTRINSIC PONTINE GLIOMA; T-CELL LYMPHOMA; GENE-EXPRESSION; PHASE-II; THERAPEUTIC TARGET; SOMATIC MUTATIONS; CHEMICAL PROBE;

D O I：

10.3390/cancers16244149

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Among the most significant discoveries from cancer genomics efforts has been the critical role of epigenetic dysregulation in cancer development and progression. Studies across diverse cancer types have revealed frequent mutations in genes encoding epigenetic regulators, alterations in DNA methylation and histone modifications, and a dramatic reorganization of chromatin structure. Epigenetic changes are especially relevant to pediatric cancers, which are often characterized by a low rate of genetic mutations. The inherent reversibility of epigenetic lesions has led to an intense interest in the development of epigenetic targeted therapies. Additionally, the recent appreciation of the interplay between the epigenome and immune regulation has sparked interest in combination therapies and synergistic immunotherapy approaches. Further, the recent appreciation of epigenetic variability as a driving force in cancer evolution has suggested new roles for epigenetic therapies in limiting plasticity and resistance. Here, we review recent progress and emerging directions in the development of epigenetic targeted therapeutics and their promise across the landscape of childhood cancers.

引用

页数：31

共 243 条

[121] A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers [J].

Lee, Ryan S. ;

Stewart, Chip ;

Carter, Scott L. ;

Ambrogio, Lauren ;

Cibulskis, Kristian ;

Sougnez, Carrie ;

Lawrence, Michael S. ;

Auclair, Daniel ;

Mora, Jaume ;

Golub, Todd R. ;

Biegel, Jaclyn A. ;

Getz, Gad ;

Roberts, Charles W. M. .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (08) :2983-2988

[122] PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors [J].

Lee, William ;

Teckie, Sewit ;

Wiesner, Thomas ;

Ran, Leili ;

Granada, Carlos N. Prieto ;

Lin, Mingyan ;

Zhu, Sinan ;

Cao, Zhen ;

Liang, Yupu ;

Sboner, Andrea ;

Tap, William D. ;

Fletcher, Jonathan A. ;

Huberman, Kety H. ;

Qin, Li-Xuan ;

Viale, Agnes ;

Singer, Samuel ;

Zheng, Deyou ;

Berger, Michael F. ;

Chen, Yu ;

Antonescu, Cristina R. ;

Chi, Ping .

NATURE GENETICS, 2014, 46 (11) :1227-1232

[123] Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma [J].

Lewis, Peter W. ;

Mueller, Manuel M. ;

Koletsky, Matthew S. ;

Cordero, Francisco ;

Lin, Shu ;

Banaszynski, Laura A. ;

Garcia, Benjamin A. ;

Muir, Tom W. ;

Becher, Oren J. ;

Allis, C. David .

SCIENCE, 2013, 340 (6134) :857-861

[124] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia [J].

Ley, Timothy J. ;

Miller, Christopher ;

Ding, Li ;

Raphael, Benjamin J. ;

Mungall, Andrew J. ;

Robertson, A. Gordon ;

Hoadley, Katherine ;

Triche, Timothy J., Jr. ;

Laird, Peter W. ;

Baty, Jack D. ;

Fulton, Lucinda L. ;

Fulton, Robert ;

Heath, Sharon E. ;

Kalicki-Veizer, Joelle ;

Kandoth, Cyriac ;

Klco, Jeffery M. ;

Koboldt, Daniel C. ;

Kanchi, Krishna-Latha ;

Kulkarni, Shashikant ;

Lamprecht, Tamara L. ;

Larson, David E. ;

Lin, Ling ;

Lu, Charles ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Payton, Jacqueline ;

Schmidt, Heather ;

Spencer, David H. ;

Tomasson, Michael H. ;

Wallis, John W. ;

Wartman, Lukas D. ;

Watson, Mark A. ;

Welch, John ;

Wendl, Michael C. ;

Ally, Adrian ;

Balasundaram, Miruna ;

Birol, Inanc ;

Butterfield, Yaron ;

Chiu, Readman ;

Chu, Andy ;

Chuah, Eric ;

Chun, Hye-Jung ;

Corbett, Richard ;

Dhalla, Noreen ;

Guin, Ranabir ;

He, An ;

Hirst, Carrie ;

Hirst, Martin ;

Holt, Robert A. ;

Jones, Steven .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) :2059-2074

[125] DNMT3A Mutations in Acute Myeloid Leukemia. [J].

Ley, Timothy J. ;

Ding, Li ;

Walter, Matthew J. ;

McLellan, Michael D. ;

Lamprecht, Tamara ;

Larson, David E. ;

Kandoth, Cyriac ;

Payton, Jacqueline E. ;

Baty, Jack ;

Welch, John ;

Harris, Christopher C. ;

Lichti, Cheryl F. ;

Townsend, R. Reid ;

Fulton, Robert S. ;

Dooling, David J. ;

Koboldt, Daniel C. ;

Schmidt, Heather ;

Zhang, Qunyuan ;

Osborne, John R. ;

Lin, Ling ;

O'Laughlin, Michelle ;

McMichael, Joshua F. ;

Delehaunty, Kim D. ;

McGrath, Sean D. ;

Fulton, Lucinda A. ;

Magrini, Vincent J. ;

Vickery, Tammi L. ;

Hundal, Jasreet ;

Cook, Lisa L. ;

Conyers, Joshua J. ;

Swift, Gary W. ;

Reed, Jerry P. ;

Alldredge, Patricia A. ;

Wylie, Todd ;

Walker, Jason ;

Kalicki, Joelle ;

Watson, Mark A. ;

Heath, Sharon ;

Shannon, William D. ;

Varghese, Nobish ;

Nagarajan, Rakesh ;

Westervelt, Peter ;

Tomasson, Michael H. ;

Link, Daniel C. ;

Graubert, Timothy A. ;

DiPersio, John F. ;

Mardis, Elaine R. ;

Wilson, Richard K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25) :2424-2433

[126] The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View [J].

Li, Baihui ;

Zheng, Yu ;

Yang, Lili .

JOURNAL OF CANCER, 2019, 10 (03) :721-729

[127] The dual HDAC and PI3K inhibitor, CUDC-907, inhibits tumor growth and stem-like properties by suppressing PTX3 in neuroblastoma [J].

Li, Mengzhen ;

Hu, Yang ;

Wang, Juan ;

Xu, Yanjie ;

Hong, Ye ;

Zhang, Li ;

Luo, Qiuyun ;

Zhen, Zijun ;

Lu, Suying ;

Huang, Junting ;

Zhu, Jia ;

Zhang, Yizhuo ;

Que, Yi ;

Sun, Feifei .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 64 (02)

[128] Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia [J].

Li, Sheng ;

Garrett-Bakelman, Francine E. ;

Chung, Stephen S. ;

Sanders, Mathijs A. ;

Hricik, Todd ;

Rapaport, Franck ;

Patel, Jay ;

Dillon, Richard ;

Vijay, Priyanka ;

Brown, Anna L. ;

Perl, Alexander E. ;

Cannon, Joy ;

Bullinger, Lars ;

Luger, Selina ;

Becker, Michael ;

Lewis, Ian D. ;

To, Luen Bik ;

Delwel, Ruud ;

Lowenberg, Bob ;

Doehner, Hartmut ;

Guzman, Monica L. ;

Hassane, Duane C. ;

Roboz, Gail J. ;

Grimwade, David ;

Valk, Peter J. M. ;

D'Andrea, Richard J. ;

Carroll, Martin ;

Park, Christopher Y. ;

Neuberg, Donna ;

Levine, Ross ;

Melnick, Ari M. ;

Mason, Christopher E. .

NATURE MEDICINE, 2016, 22 (07) :792-799

[129] Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia [J].

Li, Yunan ;

Zhang, Mingying ;

Sheng, Mengyao ;

Zhang, Peng ;

Chen, Zizhen ;

Xing, Wen ;

Bai, Jie ;

Cheng, Tao ;

Yang, Feng-Chun ;

Zhou, Yuan .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) :1065-1077

[130] SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression [J].

Lin, Chiou-Hong ;

Wong, Stephen Hon-Kit ;

Kurzer, Jason H. ;

Schneidawind, Corina ;

Wei, Michael C. ;

Duque-Afonso, Jesus ;

Jeong, Johan ;

Feng, Xuhui ;

Cleary, Michael L. .

CELL REPORTS, 2018, 23 (04) :1166-1177

← 8 9 10 11 12 13 14 15 16 17 →